Table 2. MarkVCID and ASPIRE cohort inflammation levels.
MarkVCID Cohort (n = 167) | ASPIRE Cohort (n = 131) | ||
---|---|---|---|
Marker (pg/mL) | Mean (SD) | Marker (pg/mL) | Mean (SD) |
IL-18 | 363.4 (134.3) | IL-18 | 397.6 (211.2) |
ST2 | 13146.1 (6995.1) | ST2 | 22113.2 (33073.9) |
MPO | 111567.7 (103133.0) | MPO | 254458.16 (394569.63) |
MCP-1 | 300.8 (161.9) | MCP-1 | 457.5 (222.1) |
GDF-15 | 1887.8 (1764.4) | GDF-15 | 2758.4 (3575.5) |
RAGE | 1949.3 (958.9) | RAGE | 2543.5 (1358.6) |
Inflammatory marker data measured on 167 participants in the MarkVCID Cohort and 131 participants in the ASPIRE Cohort.